Vascular tech niche Access Vascular focuses on reducing intravenous therapy complications with hydrophilic catheter materials designed to evade foreign body response, presenting a defensible niche appeal to healthcare providers seeking improved patient outcomes.

Expansion signals Recent conference activity and data presentations at INS 2025 and AVA 2024 indicate active dissemination of real-world data and potential interest from clinicians, suggesting opportunities to engage with attendees and advocate for broader product adoption.

Leadership growth Key hires in sales and marketing and governance roles (National Sales Director 2024, VP of Sales and Marketing 2023, Board appointment) signal a focused push to scale commercial efforts and establish stronger market reach.

Strategic partnerships Collaboration with Capstone Health Alliance aligns AVI with value-based healthcare objectives, presenting a pathway to contract opportunities, preferred supplier status, and bundled outcome-based purchasing.

Financial positioning Funding of 57M with current revenue in the low tens of millions places AVI in a growth phase with appetite for revenue expansion through health-system sales, channel partnerships, and expansion of product adoption in midline and PICC/vascular access markets.